Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00702-020-02235-6 http://scihub22266oqcxt.onion/10.1007/s00702-020-02235-6 32734554!7391233!32734554     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Neural+Transm+(Vienna) 2020 ; 127 (9): 1271-1274 Nephropedia Template TP {{tp|p=32734554|t=2020. Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort |pdf=|usr=}}{{32734554}} gab.com Text Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort JO: J Neural Transm (Vienna) http://www.kidney.de/pget.php?&tw=1&pmid=32734554 #FOAvip The SARS-CoV-2 virus pandemic has provoked drastic countermeasures including shutdowns of public services. We wanted to describe the effects of a 6 week shutdown of a large German botulinum toxin (BT) outpatient clinics on patients and their well-being. 45 patients (age 61.9 +/- 9.8 years, 29 females, 16 males) receiving BT therapy (319.3 +/- 201.9MU-equivalent, treatment duration 8.3 +/- 5.5 years) were surveyed with a standardised questionnaire. The shutdown delayed BT therapy by 6.6 +/- 2.3 weeks. 93% of the patients noticed increased muscle cramps and 82% increased pain reducing their quality of life by 40.2 +/- 19.5%. For 23 patients with cervical dystonia this reduction was 41.1 +/- 18.3%, for 3 patients with blepharospasm 33.3 +/- 15.3%, for 9 patients with spasticity 37.8 +/- 15.6%, for 4 patients with pain conditions 37.4 +/- 35.7% and for 3 patients with hemifacial spasm 27.5 +/- 17.1%. After the shutdown 66% of patients perceived BT therapy as more important than before, 32% perceived it as unchanged. For all patients long-term availability of BT therapy was very important or important. 98% of the patients perceived the shutdown as inadequate and felt their patient rights not respected. The shutdown confirmed the considerable burden of disease caused by dystonia, spasticity, hemifacial spasm and various pain conditions and the importance of BT therapy to treat them. Any shutdown severely affects these patients and needs to be avoided. Twit Text FOAVip Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort ????J Neural Transm (Vienna) http://www.kidney.de/pget.php?&tw=1&pmid=32734554 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32734554 #FOAvip English Wikipedia <ref>{{Cite pmid|32734554}}</ref> Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort #MMPMID32734554 Dressler D; Adib Saberi F J Neural Transm (Vienna) 2020[Sep]; 127 (9): 1271-1274 PMID32734554show ga The SARS-CoV-2 virus pandemic has provoked drastic countermeasures including shutdowns of public services. We wanted to describe the effects of a 6 week shutdown of a large German botulinum toxin (BT) outpatient clinics on patients and their well-being. 45 patients (age 61.9 +/- 9.8 years, 29 females, 16 males) receiving BT therapy (319.3 +/- 201.9MU-equivalent, treatment duration 8.3 +/- 5.5 years) were surveyed with a standardised questionnaire. The shutdown delayed BT therapy by 6.6 +/- 2.3 weeks. 93% of the patients noticed increased muscle cramps and 82% increased pain reducing their quality of life by 40.2 +/- 19.5%. For 23 patients with cervical dystonia this reduction was 41.1 +/- 18.3%, for 3 patients with blepharospasm 33.3 +/- 15.3%, for 9 patients with spasticity 37.8 +/- 15.6%, for 4 patients with pain conditions 37.4 +/- 35.7% and for 3 patients with hemifacial spasm 27.5 +/- 17.1%. After the shutdown 66% of patients perceived BT therapy as more important than before, 32% perceived it as unchanged. For all patients long-term availability of BT therapy was very important or important. 98% of the patients perceived the shutdown as inadequate and felt their patient rights not respected. The shutdown confirmed the considerable burden of disease caused by dystonia, spasticity, hemifacial spasm and various pain conditions and the importance of BT therapy to treat them. Any shutdown severely affects these patients and needs to be avoided. |*Betacoronavirus[MESH] |*Pandemics/prevention & control[MESH] |*Patient Satisfaction[MESH] |Aged[MESH] |Ambulatory Care Facilities/*trends[MESH] |Botulinum Toxins, Type A/*administration & dosage[MESH] |COVID-19[MESH] |Cohort Studies[MESH] |Coronavirus Infections/*epidemiology[MESH] |Female[MESH] |Germany/epidemiology[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Neuromuscular Diseases/drug therapy/epidemiology/psychology[MESH] |Pneumonia, Viral/*epidemiology[MESH] |SARS-CoV-2[MESH]Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perception(epmc).pdf DeepDyve Pubget Overpricing